{"id":219,"date":"2017-10-11T15:43:08","date_gmt":"2017-10-11T14:43:08","guid":{"rendered":"http:\/\/cardusocapital.com\/participations\/"},"modified":"2025-06-25T13:22:35","modified_gmt":"2025-06-25T12:22:35","slug":"portfolio","status":"publish","type":"page","link":"https:\/\/cardusocapital.com\/nl\/portfolio\/","title":{"rendered":"Portfolio"},"content":{"rendered":"<div class=\"uk-grid uk-grid-match\" data-uk-grid-match=\"{target:'.uk-panel'}\">\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>Agile Biotics BV<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2018\/07\/logo-agilebiotics.jpg\" title=\"Agile Biotics BV - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>AGILeBiotics is applying its platform technology, developing new antibiotics in the fast-growing markets of hospital-treated multidrug-resistant infections.  Via this platform a broad variety of drug candidates can be generated, leading to new antibiotics for the treatment of hospitalized patients infected by multidrug-resistant bacteria.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/agile-biotics-bv\/\" title=\"Lees meer over Agile Biotics BV\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>BioBTX<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2017\/10\/carduso-deelneming-biobtx-e1516719864230.jpg\" title=\"BioBTX - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>BioBTX BV heeft technologie ontwikkeld om met een industrieel katalytisch proces verschillende soorten biomassa om te zetten in bouwstenen voor de chemische industrie. Het Groningse bedrijf richt zich op de opschaling van het proces, zodat dit industrieel toegepast kan worden om hiermee groene en duurzame polymeren te maken.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/biobtx\/\" title=\"Lees meer over BioBTX\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"http:\/\/www.biobtx.nl\/\" title=\"Ga naar http:\/\/www.biobtx.nl\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>Bioron<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2017\/10\/carduso-deelneming-bioron.jpg\" title=\"Bioron - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p><strong>BiOrion<\/strong>\u00a0develops products for the diagnosis and treatment of fibrosis, the process of formation of excess fibrous connective tissue in organs such as liver, kidney, heart or lungs by which they may turn-out completely.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/bioron\/\" title=\"Lees meer over Bioron\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>Brainscan BV<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2018\/02\/carduso-deelneming-brainscan.jpg\" title=\"Brainscan BV - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>Brainscan BV works on the development of molecular diagnostics for psychiatric and related diseases. Patients, customers and dedicated support are the core of our work. Brainscan BV is a private company with various academic and clinical (inter) national partnerships.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/brainscan-bv\/\" title=\"Lees meer over Brainscan BV\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>BUKU<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2020\/04\/logo-buku.jpg\" title=\"BUKU - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>BUKU developed a streaming platform, for making study books digitally available in higher education. With BUKU, students can, based on an affordable subscription fee, use all the study books of the platform unlimited; Universities and colleges can therefore prescribe the most up-to-date and high-quality textbooks. Publishers thereby generate stable income. Furthermore, a significant saving on raw materials and logistical costs is achieved through the digitization of study books.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/buku\/\" title=\"Lees meer over BUKU\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"https:\/\/buku.io\/\" title=\"Ga naar https:\/\/buku.io\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>CC Diagnostics<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2018\/07\/logo-ccdiagnostics.jpg\" title=\"CC Diagnostics - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>CC Diagnostics has developed a unique test kit for detection of early stage cervical cancer. This new test is more accurate than existing methodes and measures and interpret DNA-deviations associated with the development of cervical cancer.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/cc-diagnostics\/\" title=\"Lees meer over CC Diagnostics\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"https:\/\/cc-diagnostics.com\/\" title=\"Ga naar https:\/\/cc-diagnostics.com\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>Deam<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2017\/10\/deam-1.png\" title=\"Deam - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>DEAM is een mede in Groningen gevestigd jong bedrijf dat stuurbare precisie instrumenten ontwikkelt voor minimaal invasieve operatie technieken. De uiteinden van de DEAM-instrumenten zijn vrij te bewegen in alle richtingen. Dit maakt het voor chirurgen mogelijk om ook moeilijk bereikbare plaatsen goed te behandelen. De stuurbare instrumenten hebben daarnaast grote voordelen bij de steeds meer gemeengoed wordende 3D-beeldtechnieken waarop chirurgen tijdens de operatie hun werkzaamheden kunnen zien.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/deam\/\" title=\"Lees meer over Deam\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>eRoutes<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2020\/04\/logo-eroutes.jpg\" title=\"eRoutes - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>eRoutes is a start-up based in Groningen with the mission to create a healthier world by making daily exercise accessible and fun instead of something you must do. It concerns a platform that creates globally unique recreational routes, matching the desired distance and the location of the user, wherever that may be world wide.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/eroutes\/\" title=\"Lees meer over eRoutes\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>EV Biotech<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2018\/12\/logo-evbiotech.png\" title=\"EV Biotech - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>EV Biotech ontwikkelt cellulaire fabriekjes. EV Biotech creert micro-organismen die effectief hoogwaardige molekulen kunnen produceren op een biologische manier.<br \/>\nDeze micro-organismen worden gebruikt om hoogwaardige moleculen op industriele schaal te produceren.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/ev-biotech\/\" title=\"Lees meer over EV Biotech\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>Gum Care<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2017\/10\/logo-gumcare.jpg\" title=\"Gum Care - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>Gum Irrigator B.V. is a family holding based in Groningen, the Netherlands. The Gum Irrigator apparatus provides an effective, pain-free and non-invasive solution in the treatment of gum problems with natural teeth (periodontitis) and implants (peri-implantitis). Therefore, the Gum Irrigator will provide easier access to subgingival cleaning to a larger part of the population.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/gum-care\/\" title=\"Lees meer over Gum Care\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>IVY Medical<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2020\/06\/logos-ivymedical.jpg\" title=\"IVY Medical - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>Ivy Medical is developing a new, multifunctional infusion pump called the &#8220;Ivy One&#8221;. With the Ivy One, patients no longer have to walk with the IV pole. The Ivy One can be worn as a shoulder bag and offers high wearing comfort and optimal flexibility during IV therapy. Thanks to its simple operation and safety systems, the Ivy One provides more freedom of movement for patients and great efficiency for the nursing staff.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/ivy-medical\/\" title=\"Lees meer over IVY Medical\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"https:\/\/ivymedical.nl\/\" title=\"Ga naar https:\/\/ivymedical.nl\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>Notoxins<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2020\/06\/logo-notoxins.jpg\" title=\"Notoxins - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>Overmatig zweten, hyperhydrosis genoemd, is een aandoening waarbij vaak geen onderliggende oorzaak valt aan te wijzen. Mensen die eraan leiden ondervinden met name sociale gevolgen. Natte zweetplekken en onaangename geurtjes kunnen bijdragen aan isolement en het persoonlijk zelfvertrouwen in significante mate aantasten. Notoxins ontwikkeld een behandeling d.m.v. een werkzame stof die door opname in de huid direct inwerkt op de zweetklieren.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/notoxins\/\" title=\"Lees meer over Notoxins\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"\" title=\"Ga naar \" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>Pims-e<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2019\/10\/carduso-deelneming-pimse.jpg\" title=\"Pims-e - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>PIMS-E (een spin-off bedrijf van de Rijksuniversiteit Groningen) ontwikkelt een inhalatie technologie als alternatief voor de Epipen\u2122. De werking van het middel bij personen met levensbedreigende allergische reacties, d.m.v. poederinhalatie, is razendsnel; men hoeft zichzelf geen injectie meer te geven en het middel is lang houdbaar (hoeft niet in de koelkast te worden bewaard).<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/pims-e\/\" title=\"Lees meer over Pims-e\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"https:\/\/pims-e.com\/\" title=\"Ga naar https:\/\/pims-e.com\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>Pulmotech<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2019\/10\/carduso-deelneming-pulmotech.jpg\" title=\"Pulmotech - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>PulmoTech develops an innovative sensor katheter, specifically intended for ventilated critically ill patients. The device continuously measures inside the human body, which results in a more reliable method to adequately support the patient and caregiver during mechanical ventilation.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/pulmotech\/\" title=\"Lees meer over Pulmotech\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>PureIMS<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2017\/10\/carduso-deelneming-pureims-e1516719876349.jpg\" title=\"PureIMS - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>Pure Inhalation Medication Systems (PureIMS) is a pharmaceutical company based in Roden, The Netherlands. The core activities of PureIMS are: the development, preparation and marketing of micronized drugs for effective pulmonary administration via a patented inhalation technology.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/pureims\/\" title=\"Lees meer over PureIMS\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"http:\/\/www.pureims.com\/en\/home\/\" title=\"Ga naar http:\/\/www.pureims.com\/en\/home\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>QDI<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2020\/06\/logo-qdi.jpg\" title=\"QDI - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>Kwantum Dot technologie zorgt voor een scherper r\u00f6ntgenbeeld, bij lagere dosering aan straling. Blootstelling aan r\u00f6ntgenstraling is in beginsel gevaarlijk. Straling vergroot het risico op het ontstaan van kanker. Het beperken van deze straling is dus in alle gevallen belangrijk.<\/p>\n<p>DQI ontwikkelt een systeem dat bij veel lagere stralingsdoseringen verbeterde medische informatie verstrekt, van belang voor zorgverleners en pati\u00ebnten.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/qdi\/\" title=\"Lees meer over QDI\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"https:\/\/qdisystems.com\/\" title=\"Ga naar https:\/\/qdisystems.com\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>ViroTact<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2020\/05\/logo-virotact.jpg\" title=\"ViroTact - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p><span style=\"color: #000000;\"><span style=\"font-family: Helvetica, serif;\">ViroTact ontwikkelt een innovatieve moleculaire diagnostische test om Covid-19 aan te tonen. Met de techniek is het mogelijk om snel, schaalbaar en goedkoop mensen point-of-care te testen, wat er voor zorgt dat het aantal testen in Nederland en wereldwijd verder opgeschaald kan worden.<\/span><\/span><\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/virotact\/\" title=\"Lees meer over ViroTact\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"https:\/\/www.detactdiagnostics.com\/virotact\/\" title=\"Ga naar https:\/\/www.detactdiagnostics.com\/virotact\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<div class=\"uk-width-medium-1-4\">\r\n    <div class=\"uk-panel uk-panel-box box-outline center\">\r\n        <!--<h3>VRelax<\/h3>-->\r\n        <p><img src=\"https:\/\/cardusocapital.com\/wp-content\/uploads\/2020\/04\/logo-vrelax.jpg\" title=\"VRelax - Deelneming Carduso Capital\"><\/p>\r\n        <!-- <p><p>VRelax is een wetenschappelijk gevalideerde App, die samen met pati\u00ebnten en professionals uit het UMCG is ontwikkeld. Het helpt mensen met stress, pijn en burn-outklachten door met behulp van Virtual Reality. Het VRelax dashboard biedt zorgprofessionals direct inzicht in de effecten van VRelax, en de GRIP meekijkfunctie stelt professionals in staat om samen met de pati\u00ebnt virtuele werelden te verkennen. De zorgsector veranderd snel en VRelax speelt daarop in en sluit perfect aan op de zorg van morgen.<\/p>\n<\/p> -->\r\n\r\n        \r\n            <a href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/vrelax\/\" title=\"Lees meer over VRelax\" class=\"uk-button uk-button-primary\">\r\n                <i class=\"fa fa-info-circle\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n\r\n        \r\n            <a href=\"https:\/\/vrelax.com\/\" title=\"Ga naar https:\/\/vrelax.com\/\" target=\"_blank\" class=\"uk-button uk-button-success\" rel=\"noopener\">\r\n                <i class=\"fa fa-globe\" aria-hidden=\"true\"><\/i>\r\n            <\/a>\r\n        \r\n    <\/div>\r\n<\/div>\r\n\r\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.10 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Portfolio - Carduso Capital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cardusocapital.com\/nl\/portfolio\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Portfolio - Carduso Capital\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cardusocapital.com\/nl\/portfolio\/\" \/>\n<meta property=\"og:site_name\" content=\"Carduso Capital\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-25T12:22:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cardusocapital.com\/nl\/portfolio\/\",\"url\":\"https:\/\/cardusocapital.com\/nl\/portfolio\/\",\"name\":\"Portfolio - Carduso Capital\",\"isPartOf\":{\"@id\":\"https:\/\/cardusocapital.com\/#website\"},\"datePublished\":\"2017-10-11T14:43:08+00:00\",\"dateModified\":\"2025-06-25T12:22:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cardusocapital.com\/nl\/portfolio\/#breadcrumb\"},\"inLanguage\":\"nl\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cardusocapital.com\/nl\/portfolio\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cardusocapital.com\/nl\/portfolio\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cardusocapital.com\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cardusocapital.com\/#website\",\"url\":\"https:\/\/cardusocapital.com\/\",\"name\":\"Carduso Capital\",\"description\":\"Where Science becomes Business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cardusocapital.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"nl\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Portfolio - Carduso Capital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cardusocapital.com\/nl\/portfolio\/","og_locale":"nl_NL","og_type":"article","og_title":"Portfolio - Carduso Capital","og_url":"https:\/\/cardusocapital.com\/nl\/portfolio\/","og_site_name":"Carduso Capital","article_modified_time":"2025-06-25T12:22:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cardusocapital.com\/nl\/portfolio\/","url":"https:\/\/cardusocapital.com\/nl\/portfolio\/","name":"Portfolio - Carduso Capital","isPartOf":{"@id":"https:\/\/cardusocapital.com\/#website"},"datePublished":"2017-10-11T14:43:08+00:00","dateModified":"2025-06-25T12:22:35+00:00","breadcrumb":{"@id":"https:\/\/cardusocapital.com\/nl\/portfolio\/#breadcrumb"},"inLanguage":"nl","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cardusocapital.com\/nl\/portfolio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cardusocapital.com\/nl\/portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cardusocapital.com\/nl\/"},{"@type":"ListItem","position":2,"name":"Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/cardusocapital.com\/#website","url":"https:\/\/cardusocapital.com\/","name":"Carduso Capital","description":"Where Science becomes Business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cardusocapital.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"nl"}]}},"_links":{"self":[{"href":"https:\/\/cardusocapital.com\/nl\/wp-json\/wp\/v2\/pages\/219"}],"collection":[{"href":"https:\/\/cardusocapital.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cardusocapital.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cardusocapital.com\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cardusocapital.com\/nl\/wp-json\/wp\/v2\/comments?post=219"}],"version-history":[{"count":4,"href":"https:\/\/cardusocapital.com\/nl\/wp-json\/wp\/v2\/pages\/219\/revisions"}],"predecessor-version":[{"id":942,"href":"https:\/\/cardusocapital.com\/nl\/wp-json\/wp\/v2\/pages\/219\/revisions\/942"}],"wp:attachment":[{"href":"https:\/\/cardusocapital.com\/nl\/wp-json\/wp\/v2\/media?parent=219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}